Neuraltus Pharmaceuticals Lands $14,938,357 New Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=fb1930a7-685c-486d-9fd1-fb4c0fbac841 - Date
5/25/2016 - Company Name
Neuraltus Pharmaceuticals - Mailing Address
2479 E. Bayshore Road Palo Alto, CA 94303 USA - Company Description
Neuraltus Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing innovative small molecule therapeutics for the treatment of neurodegenerative disorders. - Website
http://www.neuraltus.com - Transaction Type
Venture Equity - Transaction Amount
$14,938,357 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. 4 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
